Recombinant human IL-2 is cytotoxic to oligodendrocytes after in vitro self aggregation

Cytokine

Volumn 9, Issue 10, 1997, Pages 734-739

  Curatolo, L ^a   Valsasina, B ^a   Caccia, C ^a   Raimondi, G L ^a   Orsini, G ^a   Bianchetti, A ^a  

^a PFIZER INC   (United States)

Author keywords

In vitro cytotoxicity; Molecular aggregates; Rat oligodendrocytes; rhIL 2

Indexed keywords

NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 2;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; BRAIN CELL; CELL SURVIVAL; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; GEL FILTRATION; GLIA CELL; NERVE CELL CULTURE; NONHUMAN; OLIGODENDROGLIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; RAT; TEMPERATURE DEPENDENCE;

ANIMALIA;

EID: 0031258110     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1997.0228     Document Type: Article

References (25)

1. 1. Minami Y, Kono T, Miyazaki T, Taniguchi T (1993) The IL-2 receptor complex: its structure, function, and target genes. Annu Rev Immunol 11:245-267.
2. 2. Araujo DM, Lapchak PA, Collier B, Quirion R (1989) Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res 498:257-266.
3. 3. Hanisch UK, Seto D, Quirion R (1993) Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2. J Neurosci 13:3368-3374.
4. 4. Nisticò G (1993) Communications among central nervous system, neuroendocrine and immune systems: interleukin-2. Prog Neurobiol 40:463-475.
5. 5. Saneto RP, Altman A, Knobler RL, Johnson L, de Vellis, J (1986) Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro. Proc Natl Acad Sci USA 83:9221-9225.
6. 6. Selmaj K, Raine CS, Faroog M, Norton WT, Brosnan CF (1991) Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by Lymphotoxin. J Immunol 147:1522-1529.
7. 7. Benveniste EN, Merrill JE (1986) Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature 321:610-613.
8. 8. Satoh T, Nakamura S, Taga T, Matsuda T, Hirano T, Kishimoto T, Kaziro Y (1988) Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6. Mol Cell Biol 8:3546-3549.
9. 9. Awatsuji H, Furukawa Y, Nakajima M, Furukawa S, Hayashi K (1993) Interleukin-2 as a neurotrophic factor for supporting the survival of neurons cultured from various regions of fetal rat brain. J Neurosci Res 35:305-311.
10. 10. Kunitani M, Johnson D (1986) Model of protein conformation in the reversed-phase separation of interleukin-2 muteins. J Chromatog 371:313-333.
11. 11. Fleischmann JD, Wentworth D, Valencic F, Imbembo AL, Koehler KA (1988) Interleukin-2 self-association. Biochem Biophys Res Commun 152:879-885.
12. 12. Kaplan DR (1994) Delivery of interleukin 2 for immunotherapy. J Chromatrog B 662:315-323.
13. 13. McCarthy KD, de Vellis J (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
14. 14. Raff MC, Miller RH, Noble M (1983) A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 303:390-396.
15. 15. Gebicke-Haerter PJ, Baker J, Schobert A, Northoff H (1989) Lipopolysaccharide-free conditions in primary astrocyte cultures allow growth and isolation of microglial cells. J Neurosci 9:183-194.
16. 16. Choi DW, Maulucci-Gedde M, Kriegstein AR (1987) Glutamate neurotoxicity in cortical cell culture. J Neurosci 7:357-368.
17. 17. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of Bacteriophage T4. Nature 227:680-685.
18. 18. Eitan S, Zisling R, Cohen A, Belkin M, Hirschberg DL, Lotan M, Schwartz M (1992) Identification of an interleukin 2-like substance as a factor cytotoxic to oligodendrocytes and associated with central nervous system regeneration. Proc Natl Acad Sci USA 89:5442-5446.
19. 19. Eitan S, Schwartz M (1993) A transglutaminase that converts interleukin-2 into a factor cytotoxic to oligodendrocytes. Science 261:106-108.
20. 125] interleukin 2. Biochemistry 25:8274-8277.
21. 21. Landgraf BE, Williams DP, Murphy JR, Smith KA, Ciardelli TL (1991) Conformational perturbation of interleukin-2: a strategy for the design of cytokine analogs. Protein Struct Function Genet 9:207-216.
22. 22. Brewster ME, Hora MS, Simpkins JW, Bodor N (1991) Use of 2-hydroxypropyl-β-cyclodextrin as a solubilizing and stabilizing excipient for protein drugs. Pharm Res 8:792-795.
23. 23. Hora MS, Rana RK, Wilcox CL, Katre NV, Hirtzer P, Wolfe SN, Thomson JW (1991) Development of a lyophilized formulation of interleukin-2. Dev Biol Standard 74:295-306.
24. 24. Bergman CA, Ladmeier BJ, Kaplan DR (1991) Phase separation analysis of recombinant interleukin 2. Mol Immunol 28:99-105.
25. 25. Horwitz JI, Toner M, Tompkins RG, Yarmush ML (1993) Immobilized IL-2 preserves the viability of an IL-2 dependent cell line. Mol Immunol 30:1041-1048.